Skin and Soft Tissue
Skin and Soft Tissue
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
10
Clinical Trials
Skin and Soft Tissue
N/A
Enrolling
nct/study# N/A / 2019-0216
Immuno-Oncology Therapy for Sarcoma Patients: A Retrospective Review
Learn More
Skin and Soft Tissue
Phase II/III
Enrolling
nct/study# NCT02339571 / EA6141
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
Learn More
Skin and Soft Tissue
Phase III
Enrolling
nct/study# NCT04031677 / EA7211-EORTC
EA7211: A Randomized Phase III Study of Neoadjuvant Chemotherapy followed by Surgery versus Surgery Alone for Patients with High Risk RetroPeritoneal Sarcoma (STRASS 2)
Learn More
Skin and Soft Tissue
N/A
Enrolling
Skin and Soft Tissue
Phase III
Enrolling
nct/study# NCT06112314 / IMC-F106C-301
A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants With Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Learn More
Skin and Soft Tissue
Phase II/III
Enrolling
nct/study# NCT06947928 / MCC-2021-01
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial of IFx-Hu2.0 as An Adjunctive Therapy to Pembrolizumab in Checkpoint Inhibitor Naïve Subjects with Advanced or Metastatic Merkel Cell Carcinoma
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.